Ortho C+ (Formally known as TLC 3.0)

AOR08243

High-Dose Vitamin C & Electrolyte Formula

  • Increases collagen synthesis
  • Promotes healthy blood vessels
  • Based on Linus Pauling’s research on high-dose vitamin C
Gluten Free
Non-GMO
Soy Free
Vegetarian

$34.96 or subscribe and get 20% off

Out of stock

Maintaining heart health is imperative for a long, healthy life. Although the steps to achieve heart health are relatively simple, the western lifestyle makes it difficult for the majority of adults to stay on track. Physical activity, balanced nutrition, and low levels of stress all help maintain a healthy heart.

Medicinal research over time has led to the development of a wide variety of supplements. In 1992, research conducted by Linus Pauling and Matthias Rath lead to a revolutionary discovery showing the inverse relationship between the internal production of lipoprotein (a) and vitamin C. Rath described it as the scurvy-heart disease connection. They stated that Lp(a) can act as a surrogate for vitamin C and protect the integrity of the blood vessels in times that the human body is experiencing a vitamin C deficiency, which may develop into scurvy.

AOR’s Ortho C+ provides proper doses of the nutrients necessary for helping maintain and support cardiovascular health. Ortho C+ represents a true orthomolecular formulation with testimonials that indicate amazing results. Give your heart a little tender loving care with Ortho C+.

Discussion

Ortho C+ is formulated based on the research of Linus Pauling and Matthias Rath on lipoprotein(a) [Lp(a)]. Ortho C+ contains vitamin C, calcium, and magnesium.*

Guarantees

AOR™ guarantees that all ingredients have been included on the label. Made without wheat, gluten, dairy, soy, eggs or shellfish.

Directions

Stir 1 level tablespoon (11.5 g) into a glass of water or juice once daily, or as directed by a qualified health care practitioner.

Warning

Consult your physician before use if you’re pregnant, lactating, have a medical condition, or if you’re taking any medication. Keep out of reach of children.

Sources
  • Multisource. Hypoallergenic material.
Main Applications
  • Antioxidant
  • Lead chelation
  • Collagen synthesis
  • Healthy blood vessels
  • Cardiovascular suppor
Disclaimer

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Serving Size: 1 Tablespoon (11.5 g) / Servings Per Container: 20
Per 1 Tablespoon (11.5 g)
Amount Per Serving
% Daily Value
Vitamin C (from ascorbic acid, calcium and magnesium ascorbates)
3,000 mg
3,333%
Calcium (from calcium carbonate, calcium ascorbate)
540 mg
41%
Magnesium (from magnesium carbonate, magnesium ascorbate)
340 mg
81%
Potassium (from potassium bicarbonate)
100 mg
2%
L-Lysine
3,000 mg
L-Proline
2,000 mg
L-Taurine
250 mg

† Daily Value not established.

Other Ingredients: silicon dioxide, natural lemon flavor (maltodextrin, dextrose, acacia gum and tricalcium phosphate) and propylene glycol.

Boonmark NW, Lou XJ, Yang ZJ, Schwartz K, Zhang JL, Rubin EM, Lawn RM. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. J Clin Invest. 1997 Aug 1;100(3):558-64.

Lippi G, Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci. 2003 Feb; 40(1): 1-42.

Price KD, Price CS, Reynolds RD. Hyperglycemia-induced latent scurvy and atherosclerosis: the scorbutic-metaplasia hypothesis. Med Hypotheses. 1996 Feb; 46(2): 119-29.

Rath M. and Pauling L. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. PNAS. 87(23): 9388-90. Rath M, Pauling L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. PNAS. 1990 Aug; 87(16): 6204-7.

Rath M. Lipoprotein(a) reduction by ascorbate. J Orthomolec Med. 1992 Aug; 7(1): 81-2.

Rath M. Reducing the risk for cardiovascular disease with nutritional supplements. J Orthomolec Med.1995; 7(3): 153-62.

Trieu VN, Zioncheck TF, Lawn RM, McConathy WJ. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem. 1991 Mar 25; 266(9): 5480-5.

Willis GC. The reversibility of atherosclerosis. CMAJ. 1957 Jul 15; 77(2): 106-9.

Please select a start rating
{{review.user_complete_name}}
{{review.date | date:'medium'}}
{{review.comment}}
Comment pending for approval
Reply
{{child.user_complete_name}}
{{child.date | date:'medium'}}
{{child.comment}}
Comment pending for approval
Reply
{{child2.user_complete_name}}
{{child2.date | date:'medium'}}
{{child2.comment}}
Comment pending for approval
Reply